Rachel L. Mintz
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 4
-
- Nanoplatforms for cancer theranostics 5
-
- CRISPR and Genetic Engineering 7
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 6
- Single-cell and spatial transcriptomics 3
-
- Cancer, Hypoxia, and Metabolism 3
-
- Advanced Nanomaterials in Catalysis 3
- Partner nations
- United StatesChinaCanada
In The Last Decade
Rachel L. Mintz
27 papers receiving 629 citations
Peers
Comparison fields: 5 of 91
- Biomaterials 117
- Biomedical Engineering 209
- Nephrology 33
- Molecular Biology 292
- Business and International Management 8
Countries citing papers authored by Rachel L. Mintz
This map shows the geographic impact of Rachel L. Mintz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel L. Mintz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel L. Mintz more than expected).
Fields of papers citing papers by Rachel L. Mintz
This network shows the impact of papers produced by Rachel L. Mintz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel L. Mintz. The network helps show where Rachel L. Mintz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel L. Mintz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 31 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 31 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 29 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 40 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 6 | |
| 15 | 2021 | 42 | |
| 16 | 2021 | 4 | |
| 17 | 2019 | 78 | |
| 18 | 2019 | 72 | |
| 19 | 2018 | 11 | |
| 20 | Selected statistics for January 1981. | 1981 | 2 |
About Rachel L. Mintz
Rachel L. Mintz is a scholar working on Biomaterials, Cancer Research and Molecular Biology, having authored 30 papers that have together received 632 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Single-cell and spatial transcriptomics (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). The work is most often cited by research in Biomaterials (117 citations), Biomedical Engineering (209 citations) and Nephrology (33 citations). Rachel L. Mintz has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Mingqiang Li, Yeh‐Hsing Lao, Yu Tao, Kam W. Leong, Dan Shao, Ke Yi, Hanze Hu, Huimin Kong, Malvika Solanki and Christine N. Metz.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.